Sponsor Pipeline

Shanghai Miracogen Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05754853 A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of… Advanced or Metastatic Urothelium Cancer Recruiting
NCT06976190 A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment… Recurrent or Metastatic Nasopharyngeal Carcinoma Recruiting
Phase 2
NCT04868162 A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or… Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck Recruiting
NCT05126719 A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent… Recurrent or Metastatic Nasopharyngeal Carcinoma Active, Not Recruiting
Phase 1/2
NCT04492488 A Study of MRG002 in Patients with HER2-Positive Advanced Solid Tumors and Locally… Advanced Solid Tumors Active, Not Recruiting
Disease Areas
Gastric Cancer (1)
Get alerts when Shanghai Miracogen Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free